Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The current gold standard for treatment of chronic hepatitis C is pegylated interferon plus
ribavirin. Drug administration accuracy and ease of use will definitely determine treatment
effectiveness. This is the idea behind the development and usage of the PegIntron pen
(PegPen). Therefore, it is worthwhile to evaluate patients' satisfaction with this novel
device. The results of the study will be used to improve PegPen training techniques for
patients and health care providers.